P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
Bahlis NJ., Trudel S., Quach H., Popat R., Lonial S., Orlowski RZ., Kim K., Mateos M-V., Pawlyn C., Ramasamy K., Martinez-Lopez J., Casas-Avilés I., Spirli A., Gong J., Amatangelo M., Katz J., Maciag P., Peluso T., Richardson P.